An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis
Authors:
- Michele D. BishopMBMichele D. Bishop
- Eliza M. ParkerEPEliza M. Parker
- Andres GelrudAGAndres Gelrud
- Steven D. FreedmanSFSteven D. Freedman
- 1 January 2003
- journal article
- Published by Elsevier in Pancreatology
- Vol. 3 (1) , 36-40
Abstract
Pain in patients with chronic pancreatitis is difficult to manage. We examined if an enteral formulation containing medium-chain triglycerides (MCT) and hydrolyzed peptides would (1) minimally stimulate the exocrine pancreas by blunting cholecystokinin release and (2) decrease pain in patients with chronic pancreatitis. In the first part of the study, on separate days, 6 healthy controls consumed a standard enteral formulation, an enteral formulation containing MCT and hydrolyzed peptides, and a high-fat meal. Baseline and postprandial plasma cholecystokinin (CCK) concentrations were analyzed. Subsequently, 8 patients with chronic pancreatitis were enrolled and instructed to complete a visual analog pain assessment for a baseline period of 2 weeks followed by three cans per day of the enteral formulation containing MCT and hydrolyzed peptides for 10 weeks. Mean CCK levels for our control subjects were 0.46 +/- 0.29 pM at baseline, 10.75 +/- 0.45 pM in response to the high-fat meal, and 7.9 +/- 1.25 pM in response to the standard enteral formulation. Of note, CCK levels were 1.43 +/- 0.72 pM in response to the enteral supplement containing MCT and hydrolyzed peptides. In patients with chronic pancreatitis, the average improvement in pain scores from baseline to the conclusion of the study was 61.8% (p = 0.01). This corresponded to a clinical improvement in 6 of the 8 patients. A complete enteral supplement containing MCT and hydrolyzed peptides minimally increases plasma CCK levels. This therapy may be effective in reducing postprandial pain associated with chronic pancreatitis.Keywords
This publication has 18 references indexed in Scilit:
- Cholecystokinin (CCK) Secretion in Patients with Severe Short Bowel Syndrome (SSBS)Digestive Diseases and Sciences, 2001
- Plasma Concentrations of Neurotensin and CCK in Patients with Chronic Pancreatitis with and without Enzyme SubstitutionPancreas, 1991
- Effect of enteral nutrition on exocrine pancreatic functionThe American Journal of Surgery, 1991
- Basal and Postprandial Cholecystokinin Values in Chronic Pancreatitis with and without Abdominal PainDigestion, 1991
- Effect of Enteral Nutrition on Human Pancreatic SecretionsJournal of Parenteral and Enteral Nutrition, 1987
- Release of radioimmunologic cholecystokinin in human subjectsThe American Journal of Surgery, 1984
- Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitisDigestive Diseases and Sciences, 1983
- Effect of elemental diet on pancreatic secretionThe American Journal of Surgery, 1974
- Pancreatic Secretion in Response to jejunal Feeding of Elemental DietAnnals of Surgery, 1974
- Pancreozymin bioassay in man based on pancreatic enzyme secretion: potency of specific amino acids and other digestive productsJournal of Clinical Investigation, 1970